Long non‑coding RNA colon cancer‑associated transcript 2 may promote esophageal cancer growth and metastasis by regulating the Wnt signaling pathway

Wang,Xiuchun; Wang,Xuemei

doi:10.3892/ol.2019.10488

Long non‑coding RNA colon cancer‑associated transcript 2 may promote esophageal cancer growth and metastasis by regulating the Wnt signaling pathway

Authors:
- Xiuchun Wang
- Xuemei Wang
View Affiliations

Affiliations: Department of Vascular Intervention, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, P.R. China, Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: June 18, 2019 https://doi.org/10.3892/ol.2019.10488
Pages: 1745-1754
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate how long non‑coding (lnc)RNA colon cancer‑associated transcript 2 (CCAT2) regulates the proliferation, invasion and metastasis of esophageal cancer cells via the Wnt signaling pathway. The expression of lncRNA CCAT2 was quantified by reverse transcription‑quantitative PCR in four esophageal cancer cell lines (Eca‑109, EC9706, KYSE150 and TE‑1) and normal human esophageal epithelial cells (HEECs). The effect of silencing CCAT2 (si‑CCAT2) and inhibiting Wnt signaling (using the inhibitor FH535) on the proliferation, migration and invasion of Eca‑109 cells was measured by MTT, wound‑healing and Transwell invasion assays. Flow cytometry was used to evaluate apoptosis in si‑CCAT2 Eca‑109 cells. The expression of β‑catenin and proliferating cell nuclear antigen (PCNA) proteins was detected by immunohistochemistry. The pro‑apoptotic protein Bax, cyclin D1 and Wnt target proteins, including c‑Myc and adenomatous polyposis coli (APC), were detected by western blotting. LncRNA CCAT2 was highly expressed in the four esophageal cancer cell lines compared with the HEEC cells. The expression of CCAT2 was significantly decreased in si‑CCAT2 Eca‑109 cells. Treatment with si‑CCAT2 and FH535 alone or in combination significantly inhibited the proliferation, migration and invasion of Eca‑109 cells. The treatments also promoted apoptosis, upregulated the expression of Bax and APC proteins, and downregulated β‑catenin, PCNA, cyclin D1 and c‑Myc proteins. In summary, lncRNA CCAT2 is upregulated in esophageal cancer cells and the knockdown of lncRNA CCAT2 inhibits their proliferation, migration and invasion via the Wnt signaling pathway.

View Figures

View References

1	Bajpai M, Das KM, Lefferts J, Lisovsky M, Mashimo H, Phillips WA, Srivastava A and To H: Molecular epidemiology of and genetic susceptibility to esophageal cancer. Ann N Y Acad Sci. 1325:40–48. 2014. View Article : Google Scholar : PubMed/NCBI
2	Napier KJ, Scheerer M and Misra S: Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
3	Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M and Tanaka H: Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 23:233–242. 2013. View Article : Google Scholar : PubMed/NCBI
4	Wang J, Qiu M, Xu Y, Li M, Dong G, Mao Q, Yin R and Xu L: Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma. Tumour Biol. 36:5523–5528. 2015. View Article : Google Scholar : PubMed/NCBI
5	Łaźniak S, Lutkowska A, Wareńczak-Florczak Ż, Sowińska A, Tsibulski A, Roszak A, Sajdak S and Jagodziński PP: The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population. Arch Gynecol Obstet. 297:1285–1292. 2018. View Article : Google Scholar : PubMed/NCBI
6	Jing X, Liang H, Cui X, Han C, Hao C and Huo K: Long noncoding RNA CCAT2 can predict metastasis and a poor prognosis: A meta-analysis. Clin Chim Acta. 468:159–165. 2017. View Article : Google Scholar : PubMed/NCBI
7	Kasagi Y, Oki E, Ando K, Ito S, Iguchi T, Sugiyama M, Nakashima Y, Ohgaki K, Saeki H, Mimori K and Maehara Y: The expression of CCAT2, a novel long noncoding RNA transcript, and rs6983267 single-nucleotide polymorphism genotypes in colorectal cancers. Oncology. 92:48–54. 2017. View Article : Google Scholar : PubMed/NCBI
8	Lang HL, Hu GW, Zhang B, Kuang W, Chen Y, Wu L and Xu GH: Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2. Oncol Rep. 38:785–798. 2017. View Article : Google Scholar : PubMed/NCBI
9	Ozawa T, Matsuyama T, Toiyama Y, Takahashi N, Ishikawa T, Uetake H, Yamada Y, Kusunoki M, Calin G and Goel A: CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 ‘gene desert’, serve as important prognostic biomarkers in colorectal cancer. Ann Oncol. 28:1882–1888. 2017. View Article : Google Scholar : PubMed/NCBI
10	Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, et al: CCAT2, a novel long non-coding RNA in breast cancer: Expression study and clinical correlations. Oncotarget. 4:1748–1762. 2013. View Article : Google Scholar : PubMed/NCBI
11	Wang YJ, Liu JZ, Lv P, Dang Y, Gao JY and Wang Y: Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2. Am J Cancer Res. 6:2651–2660. 2016.PubMed/NCBI
12	Zheng J, Zhao S, He X, Zheng Z, Bai W, Duan Y, Cheng S, Wang J, Liu X and Zhang G: The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Biochem Biophys Res Commun. 480:508–514. 2016. View Article : Google Scholar : PubMed/NCBI
13	Ma Y, Hu X, Shang C, Zhong M and Guo Y: Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt/β-catenin pathway. Tumour Biol. 39:10104283177176702017. View Article : Google Scholar : PubMed/NCBI
14	Qiu M, Xu Y, Yang X, Wang J, Hu J, Xu L and Yin R: CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol. 35:5375–5380. 2014. View Article : Google Scholar : PubMed/NCBI
15	Cai Y, He J and Zhang D: Suppression of long non-coding RNA CCAT2 improves tamoxifen-resistant breast cancer cells' response to tamoxifen. Mol Biol (Mosk). 50:821–827. 2016.(In Russian). PubMed/NCBI
16	Deng X, Zhao Y, Wu X and Song G: Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer. Biomed Pharmacother. 91:1160–1166. 2017. View Article : Google Scholar : PubMed/NCBI
17	Fan YH, Fang H, Ji CX, Xie H, Xiao B and Zhu XG: Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis. Clin Chim Acta. 466:120–126. 2017. View Article : Google Scholar : PubMed/NCBI
18	Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, et al: Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2. Mol Cell. 61:520–534. 2016. View Article : Google Scholar : PubMed/NCBI
19	Zhang X, Xu Y, He C, Guo X, Zhang J, He C, Zhang L, Kong M, Chen B and Zhu C: Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 111:834–839. 2015. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Mizushima T, Nakagawa H, Kamberov YG, Wilder EL, Klein PS and Rustgi AK: Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res. 62:277–282. 2002.PubMed/NCBI
22	Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z, Li R, Zhang Z, Li Z, Dong S, et al: miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway. Oncotarget. 6:10964–10977. 2015. View Article : Google Scholar : PubMed/NCBI
23	Jia Y, Yang Y, Zhan Q, Brock MV, Zheng X, Yu Y, Herman JG and Guo M: Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer. J Mol Diagn. 14:577–585. 2012. View Article : Google Scholar : PubMed/NCBI
24	Shi M, Cheng J, He Y, Jiang Z, Bodinga BM, Liu B, Chen H and Li Q: Effect of FH535 on in vitro maturation of porcine oocytes by inhibiting WNT signaling pathway. Anim Sci J. 89:631–639. 2018. View Article : Google Scholar : PubMed/NCBI
25	Pang Y, Liu J, Li X, Zhang Y, Zhang B, Zhang J, Du N, Xu C, Liang R, Ren H, et al: Nano Let7b sensitization of eliminating esophageal cancer stemlike cells is dependent on blockade of Wnt activation of symmetric division. Int J Oncol. 51:1077–1088. 2017. View Article : Google Scholar : PubMed/NCBI
26	Cao B, Yang W, Jin Y, Zhang M, He T, Zhan Q, Herman JG, Zhong G and Guo M: Silencing NKD2 by promoter region hypermethylation promotes esophageal cancer progression by activating Wnt signaling. J Thorac Oncol. 11:1912–1926. 2016. View Article : Google Scholar : PubMed/NCBI
27	Zang B, Huang G, Wang X and Zheng S: HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway. Int J Clin Exp Pathol. 8:13687–13694. 2015.PubMed/NCBI
28	Zhang M, Linghu E, Zhan Q, He T, Cao B, Brock MV, Herman JG, Xiang R and Guo M: Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling. Oncotarget. 7:17957–17969. 2016.PubMed/NCBI
29	Gustafson CT, Mamo T, Shogren KL, Maran A and Yaszemski MJ: FH535 suppresses osteosarcoma growth in vitro and inhibits Wnt signaling through tankyrases. Front Pharmacol. 8:2852017. View Article : Google Scholar : PubMed/NCBI
30	Suknuntha K, Thita T, Togarrati PP, Ratanachamnong P, Wongtrakoongate P, Srihirun S, Slukvin I and Hongeng S: Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines. Int J Hematol. 105:196–205. 2017. View Article : Google Scholar : PubMed/NCBI
31	Wen D, Liao T, Ma B, Qu N, Shi RL, Lu ZW, Wang YL, Wei WJ and Ji QH: Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy. Cancer Med. 7:285–296. 2018. View Article : Google Scholar : PubMed/NCBI
32	Liu J, Li G, Liu D and Liu J: FH535 inhibits the proliferation of HepG2 cells via downregulation of the Wnt/β-catenin signaling pathway. Mol Med Rep. 9:1289–1292. 2014. View Article : Google Scholar : PubMed/NCBI
33	Gedaly R, Galuppo R, Daily MF, Shah M, Maynard E, Chen C, Zhang X, Esser KA, Cohen DA, Evers BM, et al: Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535. PLoS One. 9:e992722014. View Article : Google Scholar : PubMed/NCBI
34	Chen Y, Rao X, Huang K, Jiang X, Wang H and Teng L: FH535 inhibits proliferation and motility of colon cancer cells by targeting Wnt/β-catenin signaling pathway. J Cancer. 8:3142–3153. 2017. View Article : Google Scholar : PubMed/NCBI
35	Guo H, Hu G, Yang Q, Zhang P, Kuang W, Zhu X and Wu L: Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells. Oncotarget. 7:81806–81814. 2016. View Article : Google Scholar : PubMed/NCBI
36	Huang JL, Liao Y, Qiu MX, Li J and An Y: Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma. Tumour Biol. 39:10104283177113142017. View Article : Google Scholar : PubMed/NCBI
37	Sarrafzadeh S, Geranpayeh L, Tasharrofi B, Soudyab M, Nikpayam E, Iranpour M, Mirfakhraie R, Gharesouran J and Ghafouri-Fard S and Ghafouri-Fard S: Expression study and clinical correlations of MYC and CCAT2 in breast cancer patients. Iran Biomed J. 21:303–311. 2017. View Article : Google Scholar : PubMed/NCBI
38	Wang B, Liu M, Zhuang R, Jiang J, Gao J, Wang H, Chen H, Zhang Z, Kuang Y and Li P: Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt/β-catenin pathway in epithelial ovarian carcinoma cells. Oncol Lett. 15:3369–3375. 2018.PubMed/NCBI
39	Cai Y, He J and Zhang D: Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. Onco Targets Ther. 8:2657–2664. 2015.PubMed/NCBI